123 related articles for article (PubMed ID: 5170671)
1. [Preparation of factor IX concentrate with the use of DEAE-cellulose and its therapeutic results].
Uszyński L; Poszwiński P
Acta Haematol Pol; 1971; 2(2):109-14. PubMed ID: 5170671
[No Abstract] [Full Text] [Related]
2. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
Uszyński L; Poszwiński P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin complex concentrates: preparation, properties, and clinical uses.
White GC; Lundblad RL; Kingdon HS
Curr Top Hematol; 1979; 2():203-44. PubMed ID: 318075
[No Abstract] [Full Text] [Related]
4. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
Haanen C; McShine RL; Kunst A
Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
[No Abstract] [Full Text] [Related]
5. [A factor IX-concentrate for the treatment of haemophilia B].
Suomela H; Myllylä G
Duodecim; 1971; 87(1):31-8. PubMed ID: 5539580
[No Abstract] [Full Text] [Related]
6. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
7. [The P.P.S.B. coagulant fraction].
Soulier JP; Steinbuch M
Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
[No Abstract] [Full Text] [Related]
8. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
[TBL] [Abstract][Full Text] [Related]
9. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
Middleton SM; Bennett IH; Smith JK
Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
[No Abstract] [Full Text] [Related]
10. [Prevention of severe haemophilia B with a factor IX concentrate (author's transl)].
Ludwig E; Lechner K
Dtsch Med Wochenschr; 1974 Jun; 99(25):1355-61. PubMed ID: 4836072
[No Abstract] [Full Text] [Related]
11. Studies on the prolonged prothrombin time in haemophilia BM.
Elödi S
Thromb Diath Haemorrh; 1973 May; 29(2):247-52. PubMed ID: 4796945
[No Abstract] [Full Text] [Related]
12. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
Orstavik KH
Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
[TBL] [Abstract][Full Text] [Related]
13. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
[TBL] [Abstract][Full Text] [Related]
14. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
Pechet L; Smith JA
Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
[No Abstract] [Full Text] [Related]
15. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and clinical use of a new factor IX concentrate].
Lopaciuk S; Poszwiński P
Acta Haematol Pol; 1978; 9(2):107-12. PubMed ID: 665130
[TBL] [Abstract][Full Text] [Related]
17. Factor IX concentrates .
Ménaché D
Thromb Diath Haemorrh; 1975 Jun; 33(3):600-5. PubMed ID: 1154314
[No Abstract] [Full Text] [Related]
18. Clinical use of human prothrombin complexes.
Tullis JL; Melin M; Jurigian P
N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
[No Abstract] [Full Text] [Related]
19. Prothrombin complex concentrates: clinical use.
Menache D
Ann N Y Acad Sci; 1981; 370():747-56. PubMed ID: 6791551
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody-purified factor IX--comparative thrombogenicity to prothrombin complex concentrate.
Kim HC; Matts L; Eisele J; Czachur M; Saidi P
Semin Hematol; 1991 Jul; 28(3 Suppl 6):15-9. PubMed ID: 1780766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
